home / stock / edsa / edsa quote
Last: | $ |
---|---|
Change Percent: | -0.32% |
Open: | $3.1556 |
Close: | $3.16 |
High: | $3.23 |
Low: | $3.1338 |
Volume: | 23,044 |
Last Trade Date Time: | 02/12/2020 04:42:01 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $3.1556 | $3.16 | $3.23 | $3.1338 | 23,044 | 02-12-2020 |
$ | $3.1713 | $3.17 | $3.1713 | $3.1334 | 10,348 | 02-11-2020 |
$ | $3.23 | $3.17 | $3.39 | $3.10 | 30,303 | 02-10-2020 |
$ | $3.19 | $3.23 | $3.49 | $3.19 | 107,567 | 02-07-2020 |
$ | $3.34 | $3.16 | $3.34 | $3.16 | 9,694 | 02-06-2020 |
$ | $3.1072 | $3.29 | $3.29 | $3.1072 | 13,477 | 02-05-2020 |
$ | $3.1516 | $3.22 | $3.26 | $3.15 | 11,068 | 02-04-2020 |
$ | $3.26 | $3.12 | $3.2601 | $3.1101 | 21,456 | 02-03-2020 |
$ | $3.33 | $3.15 | $3.4271 | $3.15 | 26,309 | 01-31-2020 |
$ | $3.34 | $3.36 | $3.4137 | $3.30 | 20,413 | 01-30-2020 |
$ | $3.50 | $3.39 | $3.51 | $3.31 | 39,545 | 01-29-2020 |
$ | $3.1501 | $3.42 | $3.46 | $3.1501 | 43,313 | 01-28-2020 |
$ | $3.03 | $3.15 | $3.245 | $3.013 | 35,506 | 01-27-2020 |
$ | $3.30 | $3.10 | $3.33 | $3.10 | 64,019 | 01-24-2020 |
$ | $3.30 | $3.34 | $3.3538 | $3.29 | 24,070 | 01-23-2020 |
$ | $3.35 | $3.359 | $3.53 | $3.31 | 43,883 | 01-22-2020 |
$ | $3.50 | $3.40 | $3.58 | $3.40 | 41,988 | 01-21-2020 |
$ | $3.65 | $3.58 | $3.66 | $3.55 | 40,852 | 01-20-2020 |
$ | $3.65 | $3.58 | $3.66 | $3.55 | 40,826 | 01-17-2020 |
$ | $3.69 | $3.65 | $3.72 | $3.5401 | 41,039 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Edesa Biotech Inc. Company Name:
EDSA Stock Symbol:
NYSE Market:
TORONTO, ON / ACCESSWIRE / April 11, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in the 2024 Bloom Burton & Co. Health...
TORONTO, ON / ACCESSWIRE / April 2, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management plans to participate in the following upcoming investo...
TORONTO, ON / ACCESSWIRE / March 21, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in a Fireside Chat and host one-on-one me...